PMOS Together

Research & resources on Polycystic Ovary Syndrome / Polyendocrine Metabolic Ovarian Syndrome #PMOS

Dr. Donna Vine's Lab, University of Alberta, Edmonton.

[PMOS Together @PMOSTogether]

A new trial for Heart Health and PCOS
@WCHRIUofA

[PMOS Together @PMOSTogether]

See PMOS Together website for current studies: https://t.co/XZ1ihLfyu9

[PMOS Together @PMOSTogether]

We have several studies going on in Edmonton! #YEG

We are always looking for women - with and without PCOS / PMOS - interested in participating!

Check our website for details in post below or go to our profile for more information...

[PMOS Together @PMOSTogether]

"With 30 or 40 years of research, we've realized that this is more about hormones and metabolism, not just about the ovary."

Dr. Donna Vine explains to CBC News that the name change from PCOS to PMOS will increase understanding, resulting in better care.
https://t.co/CsmLHYmURE

[PMOS Together @PMOSTogether]

More about Pathways to Care for PCOS - PMOS: https://t.co/tmUSJzcpAJ

[PMOS Together @PMOSTogether]

Polycystic Ovary Syndrome (PCOS) is now known as Polyendocrine Metabolic Ovarian Syndrome (PMOS).

In our Pathways to Care for PCOS-PMOS in Alberta, assessing cardiometabolic risk at diagnosis is the key to better care: https://t.co/DQtK8ut4aF

[PMOS Vitality ©️ @PMOSVitality]

Here is our new free beginner's guide to #PMOS formerly #pcos

https://t.co/IvA8ribhW8

[Anuja Dokras, MD MHCI PhD @AnujaDokras]

Fantastic ongoing global media interest, high impact publications and professional society endorsements of the name change from PCOS to PMOS! Awareness is the first step to set the foundation for our journey to improve clinical care, education, research and policy related to PMOS

[Lujan Research Lab @CornellOvaryLab]

A recent paper affirms that a PMOS diagnosis should be made in adolescents with clear + persistent evidence of HA & menstrual irregularity. Those with 1 feature are at ⬆️ risk & should be followed longitudinally to minimize under- & over-diagnosis. https://t.co/1UZlc63xBN

[PMOS Together @PMOSTogether]

Patient advocacy is making a difference!

[European Society of Endocrinology (ESE) @ESEndocrinology]

On May 12, at #ECE2026, global experts and patient advocacy groups announced a major renaming of Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS), to reflect the multisystem nature of the disorder @veritypcos
👉 https://t.co/YUxNWipXCy

[CSEM / SCEM @CSEM_SCEM]

CSEM supports the global name change: PCOS → PMOS (Polyendocrine Metabolic Ovarian Syndrome). Published in The Lancet. Affects 1 in 8 women worldwide. A better name = better awareness, diagnosis & care. 🔬
@MCHRImonash
#PCOSnamechange #PMOS #PCOS

[Anuja Dokras, MD MHCI PhD @AnujaDokras]

Sharing our recent publication demonstrating a link between #psychological and #metabolic health in #pcos. Depression, Anxiety, and Risk of Metabolic Syndrome in Women With Polycystic Ovary Syndrome: A Longitudinal Study https://t.co/eG48sX3JJx @aepcossociety @veritypcos

[Anuja Dokras, MD MHCI PhD @AnujaDokras]

Pleased to share our study demonstrating use of #GLP1RAs in women with #PCOS results in similar weight loss compared to controls without PCOS. @aepcossociety @PennOBGYN @pcoschallenge @veritypcos @acog @FertStert https://t.co/PHcyDi3JaH

[Anuja Dokras, MD MHCI PhD @AnujaDokras]

Glad to see our paper featured in Healio #pcos #CVD #MentalHealth @PennMedicine @PennOBGYN @aepcossociety @PCOSGurl @veritypcos @TheEndoSociety

[Anuja Dokras, MD MHCI PhD @AnujaDokras]

Fantastic opportunity to share our work on the COMET-PCOS study at #ENDO2025 #pcos #hormonal therapies #metformin @aepcossociety @PennOBGYN @verity

[Nature Reviews Endocrinology @NatureRevEndo]

New content online: Promising drugs for PCOS: targeting metabolic and endocrine dysfunctions https://t.co/qgXxIQDAnH

[PBS News @NewsHour]

Now, new understanding of a health condition affecting millions of women.

An estimated 1 in 10 women worldwide live with a hormonal disorder long known as PCOS — polycystic ovary syndrome. But the condition is getting a new name.

And as @thestephsy reports, the change is about far more than terminology. Supporters say it could lead to better diagnosis, treatment and care.

[PMOS Together @PMOSTogether]

A patient-partner asked about menopause and #PMOS/#PCOS.
Good news, 'Women with PCOS have a later menopausal transition and a lower prevalence of menopausal symptoms at age 46: A population-based birth cohort study.'

https://t.co/wFubQp7mjo
https://t.co/n2VN9tmvpi

[Androgen Excess Polycystic Ovary Syndrome Society @aepcossociety]

This large nationwide population-based study showed an increased risk of multiple reproductive cancers in reproductive age women w/ polyendocrine metabolic ovarian syndrome PMOS (formerly polycystic ovary syndrome PCOS) compared to those without PMOS/PCOS.
https://t.co/CgOnAbTwnM

[PMOS Together @PMOSTogether]

Thanks to our #PCOS-#PMOS Together team in joining the #RunForWomen. Women with #PMOS have increased risk of anxiety-depression as they learn about their diagnosis and how to manage it everyday; need for multidiscplinary care is so important.
https://t.co/n2VN9tmvpi

[Healio Women’s Health & OB/GYN @healiowomen]

❗Polyendocrine metabolic ovarian syndrome (PMOS) has become the new name for polycystic ovary syndrome (PCOS) after a global initiative.

🔗Read more: https://t.co/wHBZZllGS0